Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-040808
Filing Date
2020-08-20
Accepted
2020-08-20 16:13:39
Documents
71
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pstx-10q_20200630.htm 10-Q 2586452
2 EX-31.1 pstx-ex311_11.htm EX-31.1 17239
3 EX-31.2 pstx-ex312_10.htm EX-31.2 17215
4 EX-32.1 pstx-ex321_9.htm EX-32.1 7829
5 EX-32.2 pstx-ex322_8.htm EX-32.2 7818
6 GRAPHIC gi3xpaxiz3a1000001.jpg GRAPHIC 28107
  Complete submission text file 0001564590-20-040808.txt   8097986

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT pstx-20200630.xml EX-101.INS 1542933
8 XBRL TAXONOMY EXTENSION SCHEMA pstx-20200630.xsd EX-101.SCH 53272
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pstx-20200630_cal.xml EX-101.CAL 54524
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pstx-20200630_def.xml EX-101.DEF 199314
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE pstx-20200630_lab.xml EX-101.LAB 454124
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pstx-20200630_pre.xml EX-101.PRE 344056
Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Filer) CIK: 0001661460 (see all company filings)

EIN.: 472846548 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39376 | Film No.: 201120186
SIC: 2836 Biological Products, (No Diagnostic Substances)